Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Primary HIV infection (PHI) is important both for the individual and at a population level given the high early risk of transmission and implications for contact tracing. HIV-associated tuberculosis deaths accounted for about 25% of the total. Pneumocystis jiroveci pneumonia (PCP) remains the most common AIDS-related opportunistic infection (OI), usually occurring among those not receiving primary care. International guidelines now strongly recommend immediate initiation of antiretroviral therapy (ART) among newly diagnosed adults, irrespective of CD4 count, given evidence of reduced HIV and non-HIV related illness. Ganciclovir and foscarnet have been the mainstays of treatment of cytomegalovirus (CMV) disease. With the availability of oral valganciclovir, this drug was compared with intravenous ganciclovir as induction therapy for newly diagnosed CMV retinitis in 160 patients with AIDS. There is little currently data to support any specific ART combination in the management of patients with AIDS dementia complex.

Type

Chapter

Publication Date

2018-01-01T00:00:00+00:00

Pages

149 - 180

Total pages

31